{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:25:25Z","timestamp":1785551125222,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,8]]},"DOI":"10.7759\/cureus.30061","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T12:38:47Z","timestamp":1665232727000},"source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of Dialysis in Psoriasis: A Short Review"],"prefix":"10.7759","author":[{"given":"Pooja","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Psoriasis. Accessed. August 24, 2022: https:\/\/www.mayoclinic.org\/diseases-conditions\/psoriasis\/symptoms-causes\/syc-20355840.."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.72443","article-title":"Psoriasis in India: prevalence and pattern","volume":"76","author":"Dogra S","year":"2010","unstructured":"Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010, 76:595-601. 10.4103\/0378-6323.72443","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_887_20","article-title":"Chronic kidney disease in patients with psoriasis -a hospital based cross sectional study","volume":"12","author":"Seena P","year":"2021","unstructured":"Seena P, George S, Narayanan B, Poornimamba M, Shabna CV, Gopinath A. Chronic kidney disease in patients with psoriasis -a hospital based cross sectional study. Indian Dermatol Online J. 2021, 12:864-7. 10.4103\/idoj.IDOJ_887_20","journal-title":"Indian Dermatol Online J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1203475416655705","article-title":"2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009","volume":"20","year":"2016","unstructured":"2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009. J Cutan Med Surg. 2016, 20.375-431. 10.1177\/1203475416655705","journal-title":"J Cutan Med Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1986.00360180191028","article-title":"Continuous ambulatory peritoneal dialysis for psoriasis","volume":"146","author":"Twardowski ZJ","year":"1986","unstructured":"Twardowski ZJ, Lempert KD, Lankhorst BJ. Continuous ambulatory peritoneal dialysis for psoriasis. Arch Intern Med. 1986, 146:1177-9. 10.1001\/archinte.1986.00360180191028","journal-title":"Arch Intern Med"},{"key":"ref6","unstructured":"Skin Diseases. https.\/\/my.clevelandclinic.org\/health\/diseases\/21573-skin-diseases."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.18.05757-7","article-title":"Down-regulation of IL-10 in patients with mild psoriasis and metabolic syndrome","volume":"154","author":"Lise ML","year":"2019","unstructured":"Lise ML, Baptista TS, Petersen LE, Bauer ME, Staub HL. Down-regulation of IL-10 in patients with mild psoriasis and metabolic syndrome. G Ital Dermatol Venereol. 2019, 154:372-4. 10.23736\/S0392-0488.18.05757-7","journal-title":"G Ital Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20568","article-title":"Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2","volume":"185","author":"Reich K","year":"2021","unstructured":"Reich K, Gordon KB, Strober BE, et al.. Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2. Br J Dermatol. 2021, 185:1146-59. 10.1111\/bjd.20568","journal-title":"Br J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.042","article-title":"Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody.","volume":"76","author":"Reich K","year":"2017","unstructured":"Reich K, Armstrong AW, Foley P, et al.. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody.. J Am Acad Dermatol. 2017, 76:418-31. 10.1016\/j.jaad.2016.11.042","journal-title":"J Am Acad Dermatol"},{"key":"ref10","article-title":"Interconnection of psoriasis with kidney disease","volume":"6","author":"Shafiq MA","year":"2020","unstructured":"Shafiq MA, Gattas B, Ibetoh CN, Stratulat E. Interconnection of psoriasis with kidney disease. Journal of Middle East and North Africa Sciences. 2020, 6:20-6.","journal-title":"Journal of Middle East and North Africa Sciences"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2010.09039","article-title":"Psoriasis care: new and emerging pharmacologic trends","volume":"14","author":"Papp KA","year":"2010","unstructured":"Papp KA, Carey W. Psoriasis care: new and emerging pharmacologic trends. J Cutan Med Surg. 2010, 14:119-29. 10.2310\/7750.2010.09039","journal-title":"J Cutan Med Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-018-1868-z","article-title":"Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis","volume":"50","author":"Ungprasert P","year":"2018","unstructured":"Ungprasert P, Raksasuk S. Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2018, 50:1277-83. 10.1007\/s11255-018-1868-z","journal-title":"Int Urol Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.adengl.2016.05.025","article-title":"Kidney Disease and Psoriasis. A New Comorbidity?","volume":"107","author":"Gonz\u00e1lez-Parra E","year":"2016","unstructured":"Gonz\u00e1lez-Parra E, Daud\u00e9n E, Carrascosa JM, Olveira A, Botella R, Bonanad C, Rivera R. Kidney Disease and Psoriasis. A New Comorbidity?. Actas Dermo-Sifiliogr\u00e1ficas. 2016, 107:823-9. 10.1016\/j.adengl.2016.05.025","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.106374","article-title":"Two considerations for patients with psoriasis and their clinicians.","volume":"43","author":"Krueger GG","year":"2000","unstructured":"Krueger GG, Feldman SR, Camisa C.. Two considerations for patients with psoriasis and their clinicians.. J Am Acad Dermatol. 2000, 43:281-5. 10.1067\/mjd.2000.106374","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/jdmimsu.jdmimsu_90_22","article-title":"Nail changes in the chronic kidney failure - a cross-sectional study","volume":"17","author":"Kabra R","year":"2022","unstructured":"Kabra R, Acharya S, Shukla S, Kumar S. Nail changes in the chronic kidney failure - a cross-sectional study. J Datta Meghe Inst Med Sci. 2022, 17:2-6. 10.4103\/jdmimsu.jdmimsu_90_22","journal-title":"J Datta Meghe Inst Med Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23058","article-title":"The act of prevention: knowledge, attitudes, and perception among caretakers of kidney disease patients in rural Wardha district of Central India","volume":"14","author":"Sahu G","year":"2022","unstructured":"Sahu G, Kumar S, Acharya S, et al.. The act of prevention: knowledge, attitudes, and perception among caretakers of kidney disease patients in rural Wardha district of Central India. Cureus. 2022, 14:e23058. 10.7759\/cureus.23058","journal-title":"Cureus"},{"key":"ref17","unstructured":"The Connection Between Psoriasis and Kidney Disease. Accessed. August 24, 2022: https:\/\/aakp.org\/the-connection-between-psoriasis-and-kidney-disease\/.."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2021.03.009","article-title":"Treatment of psoriasis in end-stage renal disease patients is associated with decreased mortality: A retrospective cohort study","volume":"362","author":"Schwade MJ","year":"2021","unstructured":"Schwade MJ, Tien L, Waller JL, et al.. Treatment of psoriasis in end-stage renal disease patients is associated with decreased mortality: A retrospective cohort study. Am J Med Sci. 2021, 362:24-33. 10.1016\/j.amjms.2021.03.009","journal-title":"Am J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53017-4","article-title":"Risk of end-stage renal disease in psoriatic patients: real-world data from a nationwide population-based cohort study","volume":"9","author":"Lee E","year":"2019","unstructured":"Lee E, Han JH, Bang CH, et al.. Risk of end-stage renal disease in psoriatic patients: real-world data from a nationwide population-based cohort study. Sci Rep. 2019, 9:16581. 10.1038\/s41598-019-53017-4","journal-title":"Sci Rep"},{"key":"ref20","unstructured":"Moderate to severe psoriasis linked to chronic kidney disease, say experts. (2013). https.\/\/www.bmj.com\/press-releases\/2013\/10\/15\/moderate-severe-psoriasis-linked-chronic-kidney-disease-say-experts."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_84_19","article-title":"Psoriatic nephropathy and its correlation with hs-CRP: a case control study","volume":"11","author":"Kaur I","year":"2020","unstructured":"Kaur I, Gandhi V, Raizada A, Bhattacharya SN, Tripathi AK, Jakhar D. Psoriatic nephropathy and its correlation with hs-CRP: a case control study. Indian Dermatol Online J. 2020, 11:29-34. 10.4103\/idoj.IDOJ_84_19","journal-title":"Indian Dermatol Online J"},{"key":"ref22","unstructured":"Biologic therapy may be safe for hemodialysis patients with psoriasis. (2015). Accessed. August 24, 2022: https:\/\/www.clinicaladvisor.com\/home\/topics\/psoriasis-information-center\/biologic-therapy-may-be-safe-for-hemodialysi...."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_372_19","article-title":"Prevalence and stages of chronic kidney disease in psoriasis and psoriatic arthritis: A cross-sectional study","volume":"87","author":"Munera-Campos M","year":"2021","unstructured":"Munera-Campos M, Ferr\u00e1ndiz C, Mateo L, Prior-Espa\u00f1ol \u00c1, Carrascosa JM. Prevalence and stages of chronic kidney disease in psoriasis and psoriatic arthritis: A cross-sectional study. Indian J Dermatol Venereol Leprol. 2021, 87:321. 10.25259\/IJDVL_372_19","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-022-00547-5","article-title":"Real-world effects of biologics on renal function in psoriatic patients: a retrospective study","volume":"36","author":"Chen CB","year":"2022","unstructured":"Chen CB, Huang YT, Hsiao CC, Chang SH, Chi CC. Real-world effects of biologics on renal function in psoriatic patients: a retrospective study. BioDrugs. 2022, 36:657-66. 10.1007\/s40259-022-00547-5","journal-title":"BioDrugs"},{"key":"ref25","unstructured":"Study Sees Link Between Psoriasis, Kidney Problems. https.\/\/www.webmd.com\/skin-problems-and-treatments\/psoriasis\/news\/20131015\/study-sees-link-between-psoriasis-kidney-p...."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-019-00426-z","article-title":"Efficacy of secukinumab for plaque psoriasis in a patient on hemodialysis","volume":"9","author":"Ikuma D","year":"2020","unstructured":"Ikuma D, Oguro M, Hoshino J, et al.. Efficacy of secukinumab for plaque psoriasis in a patient on hemodialysis. CEN Case Rep. 2020, 9:55-8. 10.1007\/s13730-019-00426-z","journal-title":"CEN Case Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.11.016","article-title":"An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis","volume":"5","author":"Koike Y","year":"2019","unstructured":"Koike Y, Fujiki Y, Higuchi M, Fukuchi R, Kuwatsuka S, Murota H. An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis. JAAD Case Rep. 2019, 5:150-2. 10.1016\/j.jdcr.2018.11.016","journal-title":"JAAD Case Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2015.03.012","article-title":"Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study","volume":"78","author":"Chi CC","year":"2015","unstructured":"Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH. Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci. 2015, 78:232-8. 10.1016\/j.jdermsci.2015.03.012","journal-title":"J Dermatol Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.12968\/jorn.2009.1.2.101","article-title":"The story of early peritoneal dialysis","volume":"1","author":"Turner N","year":"2009","unstructured":"Turner N. The story of early peritoneal dialysis. Journal of Renal Nursing. 2009, 1:101. 10.12968\/jorn.2009.1.2.101","journal-title":"Journal of Renal Nursing"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/8755122520988728","article-title":"Safety and efficacy of apixaban use in peritoneal dialysis: a review of the literature","volume":"37","author":"Amani A","year":"2021","unstructured":"Amani A, Fellers CM, Eyebe A, Hall A, Howard ML. Safety and efficacy of apixaban use in peritoneal dialysis: a review of the literature. J Pharm Technol. 2021, 37:147-51. 10.1177\/8755122520988728","journal-title":"J Pharm Technol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14087","article-title":"Chronic kidney disease in psoriasis: a cohort study","volume":"18","author":"Conti A","year":"2020","unstructured":"Conti A, Giovannini L, Mandel VD, et al.. Chronic kidney disease in psoriasis: a cohort study. J Dtsch Dermatol Ges. 2020, 18:438-45. 10.1111\/ddg.14087","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref32","article-title":"Psoriasis in a patient on peritoneal dialysis: a two-sided mirror","volume":"11","author":"Rimsevicius L","year":"2017","unstructured":"Rimsevicius L, Sukackiene D, Tamulyte G, Kirkilaite G, Miglinas M. Psoriasis in a patient on peritoneal dialysis: a two-sided mirror. Iran J Kidney Dis. 2017, 11:70-3.","journal-title":"Iran J Kidney Dis"},{"key":"ref33","article-title":"IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of 'psoriatic nephropathy'","volume":"19","author":"Zadrazil J","year":"2006","unstructured":"Zadrazil J, Tich\u00fd T, Hor\u00e1k P, Nikorjakov\u00e1 I, Z\u00edma P, Krejc\u00ed K, Str\u00e9bl P. IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of 'psoriatic nephropathy'. J Nephrol. 2006, 19:382-6.","journal-title":"J Nephrol"},{"key":"ref34","article-title":"Use of peritoneal dialysis and mesothelium in non primary renal conditions","volume":"25","author":"Gotloib L","year":"2009","unstructured":"Gotloib L, Fudin R. Use of peritoneal dialysis and mesothelium in non primary renal conditions. Adv Perit Dial. 2009, 25:2-5.","journal-title":"Adv Perit Dial"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15684","article-title":"Vaccine-induced erythrodermic psoriasis in a child successfully treated with secukinumab: A case report and brief literature review","volume":"35","author":"Zhao Z","year":"2022","unstructured":"Zhao Z, Zhang X, Wang R, Wang Y, Gong L, Li C. Vaccine-induced erythrodermic psoriasis in a child successfully treated with secukinumab: A case report and brief literature review. Dermatol Ther. 2022, 35:e15684. 10.1111\/dth.15684","journal-title":"Dermatol Ther"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013800","article-title":"Peritoneal dialysis versus haemodialysis for people commencing dialysis","author":"Pei J","year":"2020","unstructured":"Pei J, Ethier I, Hudson RE, et al.. Peritoneal dialysis versus haemodialysis for people commencing dialysis. Cochrane Database Syst Rev. 2020, CD013800. 10.1002\/14651858.CD013800","journal-title":"Cochrane Database Syst Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27529","article-title":"Efficacy of oral versus injectable iron in patients with chronic kidney disease: a two-year cross-sectional study conducted at a rural teaching hospital","volume":"14","author":"Agrawal S","year":"2022","unstructured":"Agrawal S, Sonawane S, Kumar S, et al.. Efficacy of oral versus injectable iron in patients with chronic kidney disease: a two-year cross-sectional study conducted at a rural teaching hospital. Cureus. 2022, 14:e27529. 10.7759\/cureus.27529","journal-title":"Cureus"},{"key":"ref38","article-title":"Diagnosis and management of psoriasis","volume":"63","author":"Kim WB","year":"2017","unstructured":"Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017, 63:278-85.","journal-title":"Can Fam Physician"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12989","article-title":"Successful treatment with ustekinumab of psoriasis vulgaris in a patient undergoing hemodialysis","volume":"43","author":"Nimmannitya K","year":"2016","unstructured":"Nimmannitya K, Tateishi C, Mizukami Y, et al.. Successful treatment with ustekinumab of psoriasis vulgaris in a patient undergoing hemodialysis. J Dermatol. 2016, 43:92-4. 10.1111\/1346-8138.12989","journal-title":"J Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.5314\/wjd.v5.i1.17","article-title":"Psoriasis treatment: Unconventional and non-standard modalities in the era of biologics","volume":"5","author":"Mahajan VK","year":"2016","unstructured":"Mahajan VK. Psoriasis treatment: Unconventional and non-standard modalities in the era of biologics. World J Dermatol. 2016, 5:17-51. 10.5314\/wjd.v5.i1.17","journal-title":"World J Dermatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.01.046","article-title":"Incidence of bullous pemphigoid and risk of mortality in the dialysis population: A retrospective cohort study","author":"Liles JE","year":"2022","unstructured":"Liles JE, Waller JL, Davis LS. Incidence of bullous pemphigoid and risk of mortality in the dialysis population: A retrospective cohort study. J Am Acad Dermatol. 2022, 10.1016\/j.jaad.2022.01.046","journal-title":"J Am Acad Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5961","article-title":"Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study","volume":"347","author":"Wan J","year":"2013","unstructured":"Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ. 2013, 347:f5961. 10.1136\/bmj.f5961","journal-title":"BMJ"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1159\/000522228","article-title":"Psoriasis and renal disorders: a large-scale population-based study in children and adults","volume":"238","author":"Friedland R","year":"2022","unstructured":"Friedland R, Kridin K, Cohen AD, Landau D, Ben-Amitai D. Psoriasis and renal disorders: a large-scale population-based study in children and adults. Dermatology. 2022, 238:904-9. 10.1159\/000522228","journal-title":"Dermatology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3863152","article-title":"A case of psoriasis vulgaris treated with brodalumab in a hemodialysis patient with end-stage renal disease due to diabetic nephropathy","volume":"2020","author":"Ishibashi M","year":"2020","unstructured":"Ishibashi M, Shiiyama R. A case of psoriasis vulgaris treated with brodalumab in a hemodialysis patient with end-stage renal disease due to diabetic nephropathy. Case Rep Dermatol Med. 2020, 2020:3863152. 10.1155\/2020\/3863152","journal-title":"Case Rep Dermatol Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1159\/000250983","article-title":"Psoriasis in North India. Geographical variations","volume":"155","author":"Bedi TR","year":"1977","unstructured":"Bedi TR. Psoriasis in North India. Geographical variations. Dermatologica. 1977, 155:310-4. 10.1159\/000250983","journal-title":"Dermatologica"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113836-effectiveness-of-dialysis-in-psoriasis-a-short-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:27Z","timestamp":1707508167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113836-effectiveness-of-dialysis-in-psoriasis-a-short-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.30061","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,8]]}}}